Market closed

Bausch Health/$BHC

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Bausch Health

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Ticker

$BHC

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Laval, Canada

Employees

20,270

Bausch Health Metrics

BasicAdvanced
$3B
Market cap
-
P/E ratio
-$0.49
EPS
0.77
Beta
-
Dividend rate
$3B
0.77
$11.46
$3.96
1.8M
1.188
0.624
-8,700
-8,887.19
1.22%
4.04%
90.99%
0.316
-2.57
-0.17
2.966
10.91%
-81.60%
3.88%
-47.01%

What the Analysts think about Bausch Health

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Bausch Health stock.

Bausch Health Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Bausch Health Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BHC

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bausch Health stock?

Bausch Health (BHC) has a market cap of $3B as of November 22, 2024.

What is the P/E ratio for Bausch Health stock?

The price to earnings (P/E) ratio for Bausch Health (BHC) stock is 0 as of November 22, 2024.

Does Bausch Health stock pay dividends?

No, Bausch Health (BHC) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Bausch Health dividend payment date?

Bausch Health (BHC) stock does not pay dividends to its shareholders.

What is the beta indicator for Bausch Health?

Bausch Health (BHC) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.